Detalhe da pesquisa
1.
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review.
Eur J Cancer;
205: 114075, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733717
2.
Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations.
Cancer Treat Rev;
127: 102751, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729086
3.
Impact of immunosuppressive agents on the management of immune-related adverse events of immune checkpoint blockers.
Eur J Cancer;
204: 114065, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643707
4.
Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma.
Cancer Res;
2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657099
5.
Drug-induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome.
Am J Hematol;
2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642007
6.
Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
Cell Death Dis;
15(2): 142, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355585
7.
Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants.
J Allergy Clin Immunol;
153(1): 256-264, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678575
8.
Antibody drug conjugates in older patients: State of the art.
Crit Rev Oncol Hematol;
193: 104212, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007063
9.
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
BMJ Med;
2(1): e000427, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920150
10.
Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology.
Eur J Cancer;
193: 113313, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748398
11.
When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.
EJHaem;
4(3): 823-826, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601857
12.
[Toxicity of targeted therapies and immunotherapy with checkpointinhibitors in Hodgkin lymphoma]. / Toxicité des thérapies ciblées et de l'immunothérapie par inhibiteurs des points de contrôle dans le lymphome de Hodgkin.
Rev Prat;
73(6): 641-650, 2023 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-37458554
13.
Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series.
J Immunother Cancer;
11(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37258037
14.
Profile and outcome of cancer patients enrolled in contemporary phase I trials.
Eur J Cancer;
188: 1-7, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178645
15.
Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study.
Cancers (Basel);
15(5)2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900299
16.
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas.
Nat Commun;
14(1): 1359, 2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914652
17.
Exploring the genetic landscape of HCV-related B-cell lymphomas using whole exome sequencing.
Leukemia;
37(6): 1388-1391, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914771
18.
Anti-cancer immune checkpoint inhibitor tolerability: summon up of savoir faire in 2023.
Ann Endocrinol (Paris);
84(3): 333-338, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990316
19.
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study.
Br J Haematol;
201(4): 673-681, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799516
20.
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
Am J Hematol;
98(4): 645-657, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606708